Price to Earnings (P/E)
since 2005
Calculation
Illumina Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income (loss) attributable to Illumina stockholders1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 109.92 | = | 494.24 | ÷ | 4.50 | 4.50 | = | 656 | ÷ | 145,900,000 | |
| Feb 11, 2020 | 43.43 | = | 296.00 | ÷ | 6.82 | 6.82 | = | 1,002 | ÷ | 147,000,000 | |
| Feb 12, 2019 | 52.00 | = | 292.20 | ÷ | 5.62 | 5.62 | = | 826 | ÷ | 147,000,000 | |
| Feb 13, 2018 | 44.63 | = | 220.44 | ÷ | 4.94 | 4.94 | = | 726 | ÷ | 147,000,000 | |
| Feb 14, 2017 | 52.01 | = | 164.46 | ÷ | 3.16 | 3.16 | = | 463 | ÷ | 146,300,000 | |
| Mar 2, 2016 | 50.07 | = | 157.20 | ÷ | 3.14 | 3.14 | = | 462 | ÷ | 147,000,000 | |
| Feb 18, 2015 | 80.83 | = | 198.62 | ÷ | 2.46 | 2.46 | = | 353 | ÷ | 143,800,000 | |
| Feb 18, 2014 | 174.33 | = | 170.40 | ÷ | 0.98 | 0.98 | = | 125 | ÷ | 128,200,000 | |
| Feb 15, 2013 | 39.96 | = | 48.73 | ÷ | 1.22 | 1.22 | = | 151 | ÷ | 124,040,754 | |
| Feb 24, 2012 | 72.33 | = | 51.22 | ÷ | 0.71 | 0.71 | = | 87 | ÷ | 122,327,021 | |
| Feb 28, 2011 | 70.92 | = | 69.40 | ÷ | 0.98 | 0.98 | = | 125 | ÷ | 127,626,004 | |
| Feb 26, 2010 | 60.45 | = | 36.32 | ÷ | 0.60 | 0.60 | = | 72 | ÷ | 120,298,934 | |
| Feb 26, 2009 | 77.14 | = | 32.16 | ÷ | 0.42 | 0.42 | = | 50 | ÷ | 121,077,875 | |
| Feb 26, 2008 | — | = | 37.23 | ÷ | -2.51 | -2.51 | = | -278 | ÷ | 111,090,078 | |
| Feb 28, 2007 | 50.48 | = | 16.80 | ÷ | 0.33 | 0.33 | = | 40 | ÷ | 120,098,536 | |
| Mar 6, 2006 | — | = | 12.79 | ÷ | -0.25 | -0.25 | = | -21 | ÷ | 82,538,624 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Illumina Inc. Annual Report.
Comparison to Competitors
Illumina Inc., P/E, long-term trends, comparison to competitors
| Illumina Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2021 | 109.92 | 40.17 | 18.82 | — | 44.49 | 31.95 | 641.48 | 28.92 | 26.72 | 19.62 | 15.09 | 27.89 |
| Feb 11, 2020 | 43.43 | 17.82 | 17.07 | 41.99 | 38.34 | 16.19 | 16.45 | 25.99 | 20.60 | 11.63 | 19.86 | 33.36 |
| Feb 12, 2019 | 52.00 | 20.60 | 14.01 | 16.81 | 29.77 | 39.13 | 15.26 | 23.74 | 33.46 | 21.58 | 18.17 | 35.19 |
| Feb 13, 2018 | 44.63 | 35.47 | 64.06 | 103.55 | 27.25 | — | 22.75 | 268.10 | 61.63 | 9.99 | 28.99 | 37.66 |
| Feb 14, 2017 | 52.01 | 16.54 | 16.03 | 20.56 | 23.02 | 32.39 | 6.83 | 20.08 | 46.14 | 28.10 | 42.64 | 30.45 |
| Mar 2, 2016 | 50.07 | 17.01 | 15.95 | 64.22 | 17.85 | 33.35 | 6.75 | 18.80 | 31.64 | 26.37 | 60.50 | 26.19 |
| Feb 18, 2015 | 80.83 | 55.08 | 22.96 | 49.80 | 23.69 | 33.06 | 12.85 | 17.15 | 13.94 | 23.03 | 118.44 | 27.26 |
| Feb 18, 2014 | 174.33 | 19.64 | 18.69 | 35.01 | 19.74 | 13.88 | 42.00 | 18.72 | 37.83 | 9.32 | 77.00 | 38.43 |
| Feb 15, 2013 | 39.96 | 11.51 | 15.68 | 30.56 | 17.73 | 14.99 | 25.20 | 19.64 | 20.94 | 13.51 | 21.42 | 22.54 |
| Feb 24, 2012 | 72.33 | — | 14.61 | 15.07 | 16.92 | 10.42 | 12.20 | 18.48 | 18.63 | 15.99 | — | 15.58 |
| Feb 28, 2011 | 70.92 | — | 10.53 | 13.99 | 18.29 | 7.86 | 10.68 | 12.23 | 116.63 | 18.63 | — | 20.87 |
| Feb 26, 2010 | 60.45 | — | 12.10 | 4.03 | 20.93 | 9.18 | 16.29 | 14.22 | 9.00 | 16.41 | — | 23.49 |
| Feb 26, 2009 | 77.14 | — | 12.06 | 7.68 | 12.56 | — | 20.29 | 11.67 | 6.53 | 10.25 | — | 15.25 |
| Feb 26, 2008 | — | — | 15.64 | 20.60 | 17.35 | 19.26 | 25.19 | 17.07 | 29.88 | 18.51 | — | 30.76 |
| Feb 28, 2007 | 50.48 | — | 25.43 | 34.64 | 19.65 | 22.40 | — | 17.02 | 21.57 | 9.18 | — | 113.28 |
| Mar 6, 2006 | — | — | 23.70 | 14.96 | 21.38 | 31.90 | 34.15 | 16.95 | 16.62 | 23.92 | — | 25.36 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Illumina Inc., P/E, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Illumina Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Feb 17, 2021 | 109.92 | 35.63 |
| Feb 11, 2020 | 43.43 | 20.58 |
| Feb 12, 2019 | 52.00 | 22.89 |
| Feb 13, 2018 | 44.63 | 34.49 |
| Feb 14, 2017 | 52.01 | 20.28 |
| Mar 2, 2016 | 50.07 | 18.89 |
| Feb 18, 2015 | 80.83 | 20.74 |
| Feb 18, 2014 | 174.33 | 19.10 |
| Feb 15, 2013 | 39.96 | 17.34 |
| Feb 24, 2012 | 72.33 | 16.25 |
| Feb 28, 2011 | 70.92 | 15.61 |
| Feb 26, 2010 | 60.45 | 11.39 |
| Feb 26, 2009 | 77.14 | 11.95 |
| Feb 26, 2008 | — | 19.74 |
| Feb 28, 2007 | 50.48 | 17.28 |
| Mar 6, 2006 | — | 20.69 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).
Comparison to Industry (Health Care)
Illumina Inc., P/E, long-term trends, comparison to industry (health care)
| Illumina Inc. | Health Care | |
|---|---|---|
| Feb 17, 2021 | 109.92 | 28.69 |
| Feb 11, 2020 | 43.43 | 20.94 |
| Feb 12, 2019 | 52.00 | 25.33 |
| Feb 13, 2018 | 44.63 | 29.68 |
| Feb 14, 2017 | 52.01 | 21.38 |
| Mar 2, 2016 | 50.07 | 19.10 |
| Feb 18, 2015 | 80.83 | 20.89 |
| Feb 18, 2014 | 174.33 | 18.14 |
| Feb 15, 2013 | 39.96 | 15.43 |
| Feb 24, 2012 | 72.33 | 15.48 |
| Feb 28, 2011 | 70.92 | 14.45 |
| Feb 26, 2010 | 60.45 | 11.43 |
| Feb 26, 2009 | 77.14 | 12.78 |
| Feb 26, 2008 | — | 18.99 |
| Feb 28, 2007 | 50.48 | 18.38 |
| Mar 6, 2006 | — | 21.11 |
Based on: 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2017-01-01), 10-K (reporting date: 2016-01-03), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2012-01-01), 10-K (reporting date: 2011-01-02), 10-K (reporting date: 2010-01-03), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2006-01-01).